We have previously demonstrated that hydrogen peroxide (H 2 O 2 ) mediates flow-induced vascular dilation in rat small mesenteric arteries. In the present study, the source of this flow-induced H 2 O 2 was explored. The arteries were pressurized to 50 mm Hg and preconstricted with phenylephrine. Intraluminal flow reversed the effect of phenylephrine, resulting in vascular dilation. Cytochrome P450 (CYP) inhibitors N-methylsulfonyl-6-(2-proparglyoxyphenyl) hexanoic acid (MS-PPOH, 10 M) and miconazole (30 M) reduced the magnitude of peak flow dilation by ~20%-30%, and reduced the duration of dilatory response by ~70-80%. Nevertheless, sulphaphenazole (10 M), a selective inhibitor of CYP 2C9, had no effect neither on the peak flow dilation nor the duration of dilatory response. Oxypurinol (100 M), an inhibitor of xanthine oxidase, attenuated the duration of dilatory response by ~60% but exerted no effect on the magnitude of peak flow dilation. Cyclosporin A (2 M), an inhibitor for mitochondrial permeability transition pore, MitoQ (300 nM), a mitochondria-targeted antioxidant, and apocynin (1 mM), a NADPH oxidase inhibitor, had no effect neither on the magnitude of peak flow dilation nor the duration of dilatory response. To further confirm the role of CYP in flow-induced H 2 O 2 production, a fluorescent probe CM-H 2 DCFDA was used to monitor the production of H 2 O 2 in the primary endothelial cells isolated from rat small mesenteric arteries. The results showed that flow-induced H 2 O 2 production was markedly reduced in MS-PPOH and miconazole pretreated endothelial cells. Taken together, our results suggest that, during flow dilation, H 2 O 2 is generated from CYP epoxygenases and xanthine oxidase.
INTRODUCTION
Blood flow through an artery generates hemodynamic shear stress which plays an important role in the control of vascular tone. In vivo studies showed that shear stress causes dilation in a variety of vessels from different species including humans [1, 2] . The mechanism of flow-induced vascular dilation has been intensively studied. It is found that flow dilation is endothelium-dependent, although the endothelial factor varies, depending on species, vascular bed, and vessel size [3] . Three principal dilators are released from endothelial cells upon stimulation by shear stress. These include nitric oxide (NO) and/or prostacyclin and/or endothelium-derived hyperpolarizing factor (EDHF) [3] .
Rat small mesenteric arteries are one of favorite models for studying the regulation of vascular tone in resistance arteries. However, there is controversy as to which vasodilator is responsible for flow dilation in rat small mesenteric arteries. Published results suggest that either NO [4] [5] [6] or EDHF [7, 8] could be the main vasodilator responsible for flow dilation in rat small mesenteric arteries. This discrepancy may be due to the differences in experimental conditions used in different laboratories. Note that different groups used different systems, pressure perfusion system [7, 8] vs peristaltic pump [6] , to generate *Address correspondence to this author at the Department of Physiology, Chinese University of Hong Kong, Hong Kong; Email: yao2068@cuhk.edu.hk intraluminar flow. Furthermore, in some studies, animals under specific conditions, such as pregnant [4] or with chronic L-NAME treatment [5] , were used for the experiments. Recently, we reported that flow dilation in rat small mesenteric arteries was mediated by EDHF, but not NO nor prostacyclin [8] . The dilation was completely abolished by catalase, suggesting an involvement of H 2 O 2 . Furthermore, exogenous application of H 2 O 2 induced vascular dilation in these arteries and it also caused hyperpolarization of smooth muscle cells in the same arteries [8] . These results suggest that endothelial H 2 O 2 , as an EDHF, is the main vasodilator responsible for flow dilation in rat small mesenteric arteries. Note that H 2 O 2 has previously been suggested to be the main vasodilator involved in flow dilation in other vascular beds [9, 10] . could result from activity of multiple enzymes/organelles including NAD(P)H oxidase, cytochrome P450 (CYP), mitochondrial respiration, and xanthine oxidase [11] . Several studies have explored the source of H 2 O 2 in flow dilation. Liu et al. show that inhibition of mitochondrial respiration reduced the flow-induced H 2 O 2 production and abolished the flow dilation in human coronary arterioles from the patients with coronary artery disease, suggesting an involvement of mitochondria-generated H 2 O 2 [12] . In contrast, two other studies [13, 14] demonstrated that NAD(P)H oxidase may be essential for shear stress-induced O 2 -generation in human umbilical vein endothelial cells.
Our previous studies showed that flow dilation in rat small mesenteric arteries is mediated by H 2 O 2 . In the current study, we investigated the source of H 2 O 2 for this flow dilation. Pharmacological inhibitors were employed to differentiate the enzymes/organelles that are responsible for H 2 O 2 production during flow dilation in rat small mesenteric arteries. The results demonstrated that, during flow dilation, H 2 O 2 is generated from CYP epoxygenases and xanthine oxidase.
MATERIALS AND METHODOLOGY

Pressure Myography
We followed the Guide for the Care and Use of Laboratory Animals published by US Institute for Laboratory Animal Research, National Research Council in 1996. Male Sprague-Dawley rats (260-280 g) were placed in a chamber and were killed by carbon dioxide. Pressure myography studies were performed as described elsewhere with slight modification [8, 15] . Briefly, a third or fourthorder mesenteric artery (about 2-3 mm long) was dissected and transferred to a pressure myograph (Danish Myotechnology) filled with oxygenated Krebs-Henseleit solution at 37°C. Krebs-Henseleit solution contained in mM: 119 NaCl, 25 NaHCO 3 , 1 MgCl 2 , 4.7 KCl, 2.5 CaCl 2 , 1.2 KH 2 PO 4 and 11 D-glucose. The artery was cannulated at both ends with glass micropipettes that were connected to independent reservoirs set at the same height and solution level to ensure no flow. Both reservoirs were filled with Krebs-Henseleit solution containing 1% BSA. The intraluminal pressure was then set to 50 mmHg by raising both reservoirs at the same time under no-flow conditions, and the artery was equilibrated for 30 min at 37°C. Phenylephrine (concentration varied to achieve similar constriction in different arteries, 0.1-4 μM) was used to preconstrict the artery to 60% -80% of its initial vessel diameter. Flow was initiated by creating the pressure difference of 5 mm Hg between inflow and outflow flow (5-6 mmHg), by moving the two reservoirs an equal distance but in opposite vertical directions at the same time. The mean intraluminal pressure was maintained at 50 mmHg throughout the flow protocol. Shear stress was calculated by equation = 4 μf -1 r -3 [16] . The initial shear force was near 10 dynes cm -2 . Flow dilation reduced the shear stress to ~3.5 dynes cm -2 . At the end of each experiment, acetylcholine (1 μM) was used to assess the viability of the endothelium. ATP (1 μM) was included in all experiments both extra-and intraluminally for the purpose of producing consistent flow dilation [15] . The external diameter of the artery was recorded continuously with a CCD (video camera module) camera using software MyoView (Photonics Engineering).
After the first dilatory response to flow, which acted as the control, the same arteries were washed then treated with a panel of different pharmacological agents both extra-and intraluminally for 30 min, followed by a second flow dilation. Dilatory response to the second flow was measured and compared to the control. The pharmacological agents included: MS-PPOH (10 M), miconazole (30 M), sulfaphenazole (10 M), oxypurinol (100 M), cyclosporin A (2 M), MitoQ (300 nM), DecylTPP (300 nM), apocynin 1 mM). Solvent (vehicle) controls were also performed, in which the arteries were treated with dimethyl sulfoxide (DMSO, 0.01%) or ethanol (0.01%)
Isolation of P rimary Mic rovascular Endothelial Ce lls (MVECs) from Rat Mesentery
Primary cultured microvascular endothelial cells were isolated from male Sprague-Dawley rat mesentery as described elsewhere [17] . Briefly, vessels of mesenteric bed were dissected and digested with 0.02% collagenase in phenol red-fee EBM basal medium for 45 min at 37 o C. Dispersed cells were pelleted and then cultured in EGM medium supplemented with 1% bovine brain extract and 1% penicillin-streptomycin. The identity of endothelial cells was verified by immunostaining with an antibody against von Willebrand Factor.
Detection of H 2 O 2 Production in Endothelial Cells
CM-H 2 DCFDA, a fluorescent dye sensitive to H 2 O 2 but not to O 2 - [18] , was used to evaluate the production of H 2 O 2 in MVECs upon shear stress. Briefly, the cells were grown on cover slips (Menzel-Glaser, Germany) to reach 70-80% confluence, and were loaded with 5 M CM-H 2 DCFDA for 40 minutes in dark at room temperature. Loaded cells were washed two times with normal physiological saline solution (NPSS) and incubated for additional 30 minutes with or without MS-PPOH (10 M) or miconazole (30 M) in NPSS containing 1% BSA and 1 M ATP. Flow was initiated by pumping normal physiological saline solution (NPSS) containing 1% BSA and 1 M ATP to a specially-designed parallel plate flow chamber, in which the cells were adhered to the bottom [19] . The flow shear stress was ~20 dyne/cm 2 . NPSS contained in mM: 140 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 10 glucose, 5 Hepes, pH 7.4. Fluorescence signals before and 1 hour after flow challenge was recorded by an Olympus FV1000 Fluoview confocal laser scanning system. An excitation wavelength of 488 nm was provided by MultilineArgon laser and the fluorescence signal was collected using a 515 nm-long pass emission filter. Changes of CM-H 2 DCFDA fluorescence in response to flow were displayed as a ratio of the fluorescence after flow relative to the fluorescence before flow (F1/F0).
Chemicals
Phenylephrine hydrochloride was obtained from RBI (Natick, USA). ATP, acetylcholine, DMSO, BSA, miconazole, oxypuinol, sulphaphenazole were purchased from Sigma-Aldrich. Apocynin and cyclosporin A were from Calbiochem. CM-H 2 DCFDA [5-(and-6)-chloromethyl-2'7'-dichlorodihydrofluorescein diacetate acetyl ester] was from Molecular Probes. Miconazole was dissolved in DMSO, MS-PPOH was dissolved in either ethanol or DMSO, MitoQ and Decyl TPP Bromide were dissolved in ethanol, oxypurinol was dissolved in 1N sodium hydroxide, and the others were dissolved in water. EBM basal medium and EGM complete medium were purchased from Lonza (Switzerland). Penicillin-streptomycin was obtained from Gibco-BRL.
Data Analysis
The peak magnitude of flow dilation was calculated as the percentage of phenylephrine-induced constriction by the following equation:
where D represents the external diameter of vessels; D f is the maximum vessel diameter after flow; D phe is the diameter after phenylephrine constriction and before flow; D i is the initial diameter without any treatment.
In most cases, flow dilation is transient with a rapid rise phase followed by a relatively slow falling phase (Fig. 1) . During the falling phase of flow transient, vessel diameter decreases exponentially. Because the decrease in diameter became very slow when flow transient approached its end, it was nearly impossible to accurately determine the "real time duration of flow dilation", which should be "from the start of flow dilation till its end". To overcome this problem and to reduce the error in estimation, the "duration of flow dilation" was arbitrarily set as the time difference between the start of flow dilation till the time when diameter of the vessel reduced to 50% of its maximal flow dilation (Fig. 1) . This arbitrary parameter of "duration of dilatory response" was used to indicate the sustainability of flow dilation. Vessels that showed less than 10% reduction in diameter were considered to demonstrate sustained dilatory response and were excluded from the calculation.
Statistical Analysis
Data are given as mean±s.e.m. The Student's two-sample t-test was used to compare the treatment groups with relevant controls. P-values <0.05 were taken to show significant differences between means. In all of the pressure myograph experiments, n is the number of mesenteric arteries from different rats.
RESULTS
Effect of CYP Epoxygenase Inhibitors on Flow Dilation
Isolated small mesenteric arteries with a vessel external diameter between 250-400 m at 50 mmHg were preconstricted with phenylephrine to a similar level (60% -80% of its initial diameter), and intraluminal flow was applied to induce dilation (Fig. 2) . After stopping the flow and testing the viability of the vessels with acetylcholine (1 M), the vessels were washed with and stabilized in KrebsHenseleit solution for 30 min to 1 hr and then reconstricted with phenylephrine. Flow was able to elicit dilation on the vessels again (Fig. 2) . There is no difference in dilatory responses, either in the peak magnitude of flow dilation or in the duration of dilatory response, from the first flow and to the second flow (Fig. 2) . In other words, the dilatory responses to flow can be repeated in the same arteries without any significant reduction in flow dilatory response.
Pharmacological inhibitors were employed to examine the possibility of CYP epoxygenase involvement in flow dilation. Previous results showed that 3 M miconazole, a nonselective CYP inhibitor [20] , failed to inhibit flowinduced dilation [8] . In the present study, we found the same agent (miconazole) at a significant higher concentration (30 M) was able to reduce the peak magnitude of flow dilation as well as the duration of dilatory responses (Fig. 3) while the vehicle control (0.01% DMSO) did not, suggesting an involvement of CYP in flow dilation. To confirm the involvement of CYP, we used a structurally distinct and highly selective epoxygenase inhibitor MS-PPOH [21] . The results showed that MS-PPOH (10 M) also decreased the peak magnitude and the duration of dilatory response while the vehicle control (0.01% ethanol) failed to do so, confirming the involvement of CYP epoxygenases in flow dilation. Sulphaphenazole (10 M), a selective inhibitor of CYP 2C9 which is an isozyme of CYP epoxygenases [22] , had no effect neither on the peak magnitude nor on the duration of dilatory response. These results suggest that CYP epoxygenases, but not the isoform CYP 2C9, were involved in flow dilation.
Effect of Xanthine Oxidase Inhibitor on Flow Dilation
Oxypurinol, a selective xanthine oxidase inhibitor [23] , was used to examine the involvement of xanthine oxidase in Fig. (1) . Determination of the duration of dilatory response to flow. The duration of dilatory response is defined as the time elapsed from the start of flow dilation till the time when the magnitude of dilation reduced to 50% of its maximal value. flow dilation. Oxypurinol (100 M) reduced the duration of dilatory response but had no effect on the peak magnitude of flow dilation (Fig. 4) . These results suggest an involvement of xanthine oxidase in flow dilation.
Effect of Mitochondria-Generated H 2 O 2 on Flow Dilation
Cyclosporin A and MitoQ w ere us ed t o examine t he involvement of mitochondrial reactive oxygen species (ROS) in fl ow dil ation. Cyclosporin A inhibits t he ope ning of t he permeability t ransition pore i n t he i nner m itochondrial membrane and t hus pr events t he produc tion of O 2 - [24] . MitoQ is an e legantly-designed m itochondria-targeted antioxidant, w hich c an s electively s cavenge m itochondriagenerated H 2 O 2 a nd o ther R OS [ 25] . D ecyltriphenylphosphonium bromide (decylTPP brom ide) is the triphenylphosphonium m oiety t hat is re sponsible for t argeting MitoQ to [25, 26] . It s erves a s a negative control fo r MitoQ t o account for a ny non-s pecific effect of l iphophilic cations [25, 26] . In e xperiments, cyclosporin A (2 M) had no effect either on the peak magnitude of flow dilation or on the dura tion of dil atory re sponse whe reas MitoQ (300 nM) reduced the d uration o f d ilatory r esponse b ut d id n ot affect the p eak m agnitude ( Fig. 5) . Howe ver, d ecylTPP brom ide (300 nM ) e xerted t he s ame effect as MitoQ (F ig. 5). N o difference i n fl ow di lation wa s found be tween MitoQ-a nd decylTPP b romide-treated ar teries ( Fig. 5) . Th erefore, th e effect of MitoQ on t he duration of dil atory response to flow was due t o t he non-s pecific effect of liphophilic cations. These data suggest that mitochondria-generated H 2 O 2 did not contribute to the flow dilation.
Effect of NADPH Oxidase Inhibitor on Flow Dilation
Apocynin is a selective inhibitor of NADPH oxidase that acts by inhibiting i ncorporation of t he p47 phox s ubunit of NADPH oxidase into the m embrane uni t [27] . Apocynin (1 mM) exerted no effect neither on the peak magnitude of flow dilation n or t he d uration o f d ilatory r esponse. H ence, o ur data suggest that NADPH oxidase was not involved in flow dilation in rat small mesenteric arteries.
Effect of MS-PPOH and Miconazole on H 2 O 2 Production in MVECs
To furt her confirm the ro le of CYP e poxygenases in flow-induced H 2 O 2 production, we monitored the change of CM-H 2 DCFDA fl uorescence i n t he pri mary c ultured mesenteric endothelial cells i n re sponse to fl ow c hallenge. CM-H 2 DCFDA is a fluorescent dye widely used to detect the change i n c ytosolic H 2 O 2 l evel [12, 18] . In experiments, exposure of c ultured e ndothelial c ells to fl ow re sulted i n a rise in C M-H 2 DCFDA f luorescence (F ig. 6a, l eft column; and 6b), indicating a flow-induced production of H 2 O 2 . This fluorescence increase w as completely a bolished in t hose cells th at w ere tr eated w ith MS-PPOH ( 10 M) ( Fig. 6a , middle c olumn; a nd 6b) or miconazole (30 M) ( Fig. 6a,  right column; a nd 6b) . As a nother c ontrol, ve hicle (0. 01% DMSO) treatment had no effect on flow-induced rise in CM-H 2 DCFDA fluorescence (Fig. 6b) . These data are consistent with those from flow dilation study, supporting an important role of CYP epoxygenases in flow-induced H 2 O 2 production.
DISCUSSION
Our pre vious s tudies [8] ha ve s howed t hat t he fl owinduced vascular dilation in rat m esenteric ar teries is m ainly mediated by H 2 O 2 , b ecause 1 ) the d ilation w as c ompletely abolished by catalase, and the inhibition can b e reversed b y washing away t he c atalase; 2 ) i n t he p resence o f a c atalase inhibitor aminotriazole, catalase loses its inhibitory effect; 3) exogenous a pplication of H 2 O 2 i nduces r elaxation in phenylephrine-preconstricted arteries and hyperpolarized the smooth m uscle c ells. In t he pr esent s tudy, we explored t he source of H 2 O 2 during flow-induced va scular d ilation in ra t small mesenteric ar teries. The r esults d emonstrated th at, during fl ow dil ation, H 2 O 2 i s g enerated f rom CYP epoxygenases and xanthine oxidase. Mitochondria-generated H 2 O 2 and NADP H oxidase are not i nvolved in the proc ess. Within the t wo s ources that c ontribute to the H 2 O 2 generation, CYP e poxygenases appear t o play a m ore important role a s the inhibition of C YP e poxygenases reduced both the peak magnitude and the duration of dilatory response, a nd it a lso s uppressed the H 2 O 2 production in MVECs. However, note that inhibition of CYP epoxygenases or xanthine oxidase alone failed to completely CYP epoxygenases m etabolize arachidonic a cid to four regioisomeric e poxyeicosatrienoic a cids ( EETs) (5, 6-, 8, 9-, 11,12-, and 14,15-EET) [28] . The EETs have been identified as E DHFs in s everal vascular be ds including c oronary a nd renal arteries [28, 29] . Based on the results that flow dilation can be m arkedly inhibited by m iconazole and 17-octadecynoic acid, Miura et al. suggested that EETs are the vasodilator responsible for fl ow dilation in hum an coronary arterioles in t he p atients w ith coronary a rtery d isease [ 30] . However, note that catalytic cycle of CYP epoxygenases can also produc e ROS, i ncluding O 2 .-, H 2 O 2 , a nd hydroxy l radicals [22, 31, 32] . H 2 O 2 thus produced m ay a ct a s a n EDHF, c ontributing t o fl ow di lation. In fa ct, l ater s tudies from the same group ha ve concluded that H 2 O 2 is the m ajor vasodilator responsible for fl ow dilation in hum an coronary arterioles [10, 12] , a lthough t hey a rgued t hat, duri ng fl ow dilation, H 2 O 2 is generated from mitochondria. In the present study, w e de monstrated a n important rol e of CYP epoxygenases in flow dila tion. As mentioned, activity of CYP epoxygenases m ay produc e E ET and H 2 O 2 , bot h o f which may act as EDHF to cause vascular dilation. Although we cannot exclude the possibility that EET thus produced may also contribute to the flow dilation, the main vasodilator appears to b e H 2 O 2 i nstead of E ET be cause our pre vious studies ha ve already de monstrated t hat H 2 O 2 scavenging could c ompletely a bolish t he fl ow d ilation [8] . F leming suggested that, among numerous CYP isoforms, CYP 2C9 is a physiologically relevant source of ROS in porcine coronary endothelial cells [22] . Recent studies showed that CYP 2C9 is i nvolved i n fl ow dil ation i n hum an pe ripheral c onduit arteries in healthy subjects and in patients with heart diseases [33] . T hus we tested the p ossible involvement of C YP 2 C9 in f low d ilation in r at s mall mesenteric arteries. O ur d ata showed t hat s ulphaphenazole, a s pecific inhibitor for C YP 2C9, did not have any effect on flow dilation, suggesting that CYP 2 C9 is no t i nvolved in t he f low d ilation o f r at s mall mesenteric arteries.
Xanthine oxi dase c atalyzes the oxi dation of xa nthine or hypoxanthine duri ng puri ne m etabolism, le ading t o t he formation of O 2 -and H 2 O 2 . It has been shown that xanthine oxidase is a s ource for O 2 -pro duction i n hum an i nternal mammary a rteries a nd s aphenous ve ins [34] . Xa nthine oxidase a lso c ontributes t o a n i ncreased R OS le vels in spontaneous hypertensive rats [35, 36] . We used oxypurinol, a s elective inhibitor of xa nthine oxi dase, to e xamine t he possible i nvolvement of xa nthine oxi dase in fl ow d ilation. The re sults s howed that oxypurinol reduced the dura tion o f dilatory re sponse t o f low, s uggesting a n i nvolvement o f xanthine oxi dase in fl ow d ilation in ra t s mall mesenteric arteries.
The electron transport chain within mitochondria can also generate O 2 -and H 2 O 2 [37] . One previous study from Liu et al. s uggests that, duri ng fl ow d ilation i n hum an c oronary arterioles, H 2 O 2 i s g enerated f rom m itochondria r espiration [12] . T heir c onclusion wa s b ased on 1) fl ow-induced H 2 O 2 production, a s de termined by H 2 DCFDA f luorescence a nd electron s pin re sonance, i s re duced by rot enone, whic h is mitochondrial c omplex I i nhibitor; 2) t he fl ow dil ation o f human co ronary r esistance arteries is almost co mpletely abolished by ro tenone, a nd fur thermore t he d ilation w as partially inhibited by myxothiazol, a mitochondrial complex III i nhibitor. These re sults are contradictory t o t he f indings from t he pre sent s tudy. In t he pre sent s tudy, we found t hat scavenging m itochondria-generated H 2 O 2 w ith MitoQ o r inhibiting mitochondrial ROS production with cyclosporin A had no e ffect on fl ow di lation, bot h a rguing a gainst a n involvement of m itochondria-generated H 2 O 2 i n f low dilation. T he r eason for t his d iscrepancy is unc lear. However, compared to the study from Liu et al. [12] , we used different animal species and d ifferent arteries. Fur thermore, the s tudy from L iu et al. u sed r otenone to inhibit mitochondria O 2 -generation [12] . T here is a controversy on whether rote none can indeed inhibit mitochondria O 2 -generation be cause rote none w as found t o s timulate mitochondria O 2 -generation i n s ome cases [38, 39] . In t he present study, we used a much superior agent MitoQ that can selectively scavenge mitochondria-generated H 2 O 2 and other ROS. T hese di fferences in e xperimental d esigns could contribute t o the c onflicting re sults about t he ro le o f mitochondria-generated H 2 O 2 in flow dilation.
NADPH oxi dase i s a nother put ative s ource of O 2 -in vascular e ndothelial c ells. It i s a membrane-bound flavocytochrome and us es bot h fl avin a nd he me groups to transfer e lectrons f rom N ADPH t o o xygen, y ielding O 2 -. Previous re ports s howed t hat la minar s hear s tress m ay generate O 2 -via NADPH oxidase in cultured human umbilical vein endothelial cells [13, 14] . In our experiments, apocynin, a s elective inhibitor for NADPH oxi dase, did not have e ffect on fl ow dil ation, suggesting t hat NA DPH oxidase is not i nvolved i n t he proc ess. Howe ver, t here i s a major d ifference in e xperimental de signs be tween ours a nd others': w e us ed i solated a rtery s egments a s e xperimental 
CONCLUSION
In summary, during flow dilation in rat small mesenteric arteries, H 2 O 2 as the dilator is generated from CYP epoxygenases and xanthine oxidase.
